These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6291362)

  • 1. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Topic N; Kramer B; Massie B
    Am Heart J; 1982 Nov; 104(5 Pt 2):1172-9. PubMed ID: 6291362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and long-term effects of captopril on left and right ventricular volumes and function in chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Am Heart J; 1982 Nov; 104(5 Pt 2):1197-203. PubMed ID: 6291366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
    Awan NA; Amsterdam EA; Hermanovich J; Bommer WJ; Needham KE; Mason DT
    Am Heart J; 1982 Apr; 103(4 Pt 1):474-9. PubMed ID: 6801943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
    Kugler J; Maskin CS; Frishman W; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1154-9. PubMed ID: 6127943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure.
    Awan NA; Needham KE; Lui H; Rutledge J; Amsterdam EA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1224-8. PubMed ID: 6753553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure.
    Hermanovich J; Awan NA; Lui H; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1211-4. PubMed ID: 6753551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
    Awan NA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN; Coxon R
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Halperin JL; Melidossian CD; McCabe CH; Schick EC; Ryan TJ
    Am Heart J; 1982 Nov; 104(5 Pt 2):1147-54. PubMed ID: 6291360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
    Cody RJ; Covit A; Schaer G; Williams G
    Am Heart J; 1982 Nov; 104(5 Pt 2):1180-3. PubMed ID: 6291363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of captopril on postural hemodynamics and autonomic responses in chronic heart failure.
    Cody RJ
    Am Heart J; 1982 Nov; 104(5 Pt 2):1190-6. PubMed ID: 6291365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
    Massie B; Kramer BL; Topic N; Henderson SG
    Circulation; 1982 Jun; 65(7):1374-81. PubMed ID: 6280890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
    Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
    Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure.
    Kugler J; Maskin C; Frishman WH; Sonnenblick EH; LeJemtel TH
    Circulation; 1982 Dec; 66(6):1256-61. PubMed ID: 6291801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
    Chatterjee K; Rouleau JL; Parmley WW
    Am Heart J; 1982 Nov; 104(5 Pt 2):1137-46. PubMed ID: 6291359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Win A; Mason DT
    Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure.
    Powers ER; Bannerman KS; Stone J; Reison DS; Escala EL; Kalischer A; Weiss MB; Sciacca RR; Cannon PJ
    Am Heart J; 1982 Nov; 104(5 Pt 2):1203-10. PubMed ID: 6753550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.